TL1A regulation of group 3 innate lymphoid cells in colitis

Active Project Grant Awarded Last action

Award ID
R01DK120985
Recipient
Awarding agency
Obligated
$2,886,083

Award facts

Completion date 73% complete
Originally
Place of performance
New York, NY 10065, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $668,149
Amendment $695,365
Amendment -$0
Amendment -$0
Amendment -$733
Amendment -$733
Amendment -$733
Amendment -$733
Amendment $381,375
Amendment $38,137
Amendment $343,238
Amendment TL1A regulation of group 3 innate lymphoid cells in colitis - inflammatory bowel disease (IBD) affects over 4 million people worldwide, causing significant… $381,375
Original award $381,375
Show all 13

Subawards

Subrecipient Amount Awarded
The Washington University STATEMENT OF WORK Dr. Brian Edelson (Co-Investigator) will provide advice, reagents, and technical expertise for the proposed experiments related to the study… $39,679
Subrecipient not on record Notwithstanding the budget contained herein, payment is contingent upon receipt of funds from the Prime Sponsor. Weill Cornell, as the Pass Through Entity… $25,425

Quick answers

Who received award R01DK120985?

R01DK120985 was awarded to Weill Medical College Of Cornell University by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on April 7, 2020.

How much is award R01DK120985 worth?

$2,886,083 has been obligated on R01DK120985.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login